Toru Sugimoto

Title: Toru Sugimoto: Innovator in Genetic Engineering

Introduction

Toru Sugimoto is a prominent inventor based in Ibaraki, Japan, known for his contributions to the field of genetic engineering. He holds three patents that focus on G protein-coupled receptor family proteins, which play a crucial role in the central nervous system.

Latest Patents

One of his latest patents is for polynucleotides encoding the SREB1 receptor. This invention provides novel G protein-coupled receptor family proteins SREB1, SREB2, and SREB3 expressed in the central nervous system. It includes genes coding for these proteins and screening methods utilizing them. The method for obtaining these proteins involves RT-PCR using mRNA extracted from human or rat brain tissue or brain-derived cells. This process allows for the creation of cDNA corresponding to the G protein-coupled receptor protein, which is then integrated into an appropriate expression vector for expression in a host cell. Another patent focuses on polynucleotides encoding the SREB3 receptor, which shares similar characteristics and methodologies as the SREB1 receptor patent.

Career Highlights

Throughout his career, Toru Sugimoto has worked with notable companies such as Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His experience in these organizations has contributed significantly to his expertise in genetic engineering and receptor protein research.

Collaborations

Some of his notable coworkers include Mitsuyuki Matsumoto and Jun Takasaki, who have collaborated with him on various projects in the field of genetic engineering.

Conclusion

Toru Sugimoto's innovative work in genetic engineering, particularly in the development of G protein-coupled receptor family proteins, has made a significant impact in the field. His patents and collaborations reflect his dedication to advancing scientific knowledge and technology.